Women's Issues Feature Package

NEW YORK, June 20, 2012 /PRNewswire/ -- The following feature package is a roundup of feature stories dealing with women's issues and is appropriate for special sections and for general use. 

For each story included in this package, you will find the first paragraph of the feature release below, as well as its headline linked to the full text.

This is the latest in a series of topical feature packages PRN will carry as part of its regular Feature News Service.  Coming up in 2012 are features on:

Women's Issues Feature Package

1. Life Quotes, Inc. Reveals Health Risks for Mom That May Increase Life Insurance Costs

DARIEN, Ill., May 12, 2012 /PRNewswire/ -- Life Quotes, Inc. and Consumer Insurance Guide, stress the importance of moms staying fit and getting in to see their doctor for their annual checkups this Mother's Day with advice from one of the world's leading fitness experts, Jackie Warner, and Sister to Sister, the non-profit organization concerned with the prevention of the #1 killer of women: heart disease.

2. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine

WORCESTER, Mass. and TORONTO, June 7, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT) announced today that an End-of-Phase II meeting has been scheduled with the United States Food and Drug Administration (FDA) in respect of the Phase II clinical trial of the AE37 breast cancer vaccine being undertaken by its wholly-owned subsidiary, Antigen Express, Inc.

3. Generex Announces Presentation of New Immune Response Data from AE37 Phase II Breast Cancer Trial at ASCO 2012

WORCESTER, Mass. and TORONTO, June 5, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT.OB) announced today that new immune response data from the on-going Phase II clinical trial of the AE37 breast cancer vaccine undertaken by Generex wholly-owned subsidiary Antigen Express, Inc. was presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) (http://chicago2012.asco.org) on June 2, 2012 in Chicago, IL.
 

4. Generex Announces ASCO 2012 Podium Presentation Showcasing Antigen Express AE37 Cancer Vaccine Technology

WORCESTER, Mass. and TORONTO, June 6, 2012 /PRNewswire/ -- Generex Biotechnology Corporation (OTCBB: GNBT.OB) announced today a podium presentation on the technology and clinical results from the on-going Phase II clinical trial of the AE37 breast cancer vaccine being developed by Generex wholly-owned subsidiary Antigen Express, Inc. The presentation was at the Annual Meeting of the American Society of Clinical Oncology (ASCO) (http://chicago2012.asco.org) on June 4, 2012 in Chicago, IL.

If you would like a copy of the complete schedule, or if you would care to comment, please email [email protected].  We welcome suggestions.  Copies of previous packages are available for the media.  Feature packages and feature photos are also available on the PR Newswire Web site, http://www.prnewswire.com/news-releases/feature-news-latest-news.

Photos that accompany releases are available via the PRN Multimedia Desk, 800-317-7677, or via the PR Newswire Photo Archive.  Select photos are available via AP PhotoExpress and AP Images.

SOURCE PR Newswire Association LLC